Avalo Therapeutics Inc. (AVTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Opaleye Management James A. Silverman | 0 | $0 | 0% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 0 | $0 | 0% | |
| 3. | Point72 Asset Management Steve Cohen | 0 | $0 | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.62 | 182,300 | Large Shareholder | 0 | 2023-06-26 | Filing | |
| $0.64 | 1,425,700 | Large Shareholder | 0 | 2023-06-26 | Filing | |
| $4.14 | 2,000 | Large Shareholder | 1,425,700 | 2023-06-20 | Filing | |
| $3.90 | 3,000 | Large Shareholder | 1,423,700 | 2023-06-16 | Filing | |
| $3.68 | 3,160 | Large Shareholder | 1,420,700 | 2023-06-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.52 | 937,404 | Large Shareholder | 731,458 | 2023-06-27 | Filing | |
| $0.61 | 2,746,138 | Large Shareholder | 1,668,862 | 2023-06-26 | Filing | |
| $3.98 | 1,270 | Large Shareholder | 0 | 2018-08-13 | Filing |
Institutional Investors' Holdings
Billionaire Hedge Funds
